Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-15

Clinical Trial Update: The Effects of Chlorhexidine/Thymol Varnish on Partial Denture Patient [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating chlorhexidine/thymol varnish for periodontal disease and dental caries in partial denture patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine/Thymol Varnish (chlorhexidine/thymol varnish)

Snippet

Sponsor: Rosa Moreno Lopez | Conditions: Periodontal Disease, Caries | Phase 4 | Status: WITHDRAWN